Diabetes
Nomopil Tablet 0.5mg .
Out of Stock
Call for price
<h2> </h2><p>10 tablets</p><p>PRESENTATION</p><p>Nomopil 0.5: Each tablet contains Repaglinide USP 0.5 mg.</p><p>Nomopil 1: Each tablet contains Repaglinide USP 1 mg.</p><p>Nomopil 2: Each tablet contains Repaglinide USP 2 mg.</p><p>DESCRIPTION</p><p>Repaglinide is an oral blood glucose-lowering drug of the meglitinide class used in the management of Type 2 diabetes mellitus</p><p>(NIDDM). Repaglinide works by causing pancreas to release more insulin into the blood stream which possesses rapid onset of action</p><p>and rapid elimination.</p><p>INDICATIONS</p><p>Repaglinide is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with type 2 diabetes mellitus</p><p>(NIDDM) whose hyperglycemia cannot be controlled satisfactorily by diet and exercise alone. It is also indicated for use in</p><p>combination with Metformin to lower blood glucose in patients whose hyperglycemia cannot be controlled by exercise, diet, and</p><p>either Repaglinide or Metformin alone.</p>
10 tablets
PRESENTATION
Nomopil 0.5: Each tablet contains Repaglinide USP 0.5 mg.
Nomopil 1: Each tablet contains Repaglinide USP 1 mg.
Nomopil 2: Each tablet contains Repaglinide USP 2 mg.
DESCRIPTION
Repaglinide is an oral blood glucose-lowering drug of the meglitinide class used in the management of Type 2 diabetes mellitus
(NIDDM). Repaglinide works by causing pancreas to release more insulin into the blood stream which possesses rapid onset of action
and rapid elimination.
INDICATIONS
Repaglinide is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with type 2 diabetes mellitus
(NIDDM) whose hyperglycemia cannot be controlled satisfactorily by diet and exercise alone. It is also indicated for use in
combination with Metformin to lower blood glucose in patients whose hyperglycemia cannot be controlled by exercise, diet, and
either Repaglinide or Metformin alone.
No additional specifications available.
No vendor information available.